| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 0 | 48.411 | 59.270 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 2.227 | 58.997 | 59.270 |
| Total Expenses - EUR | - | - | - | - | - | - | 0 | 2.159 | 43.670 | 51.483 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 0 | 68 | 15.327 | 7.787 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 0 | 2 | 14.808 | 6.200 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Dopamine Experiment S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 27.677 | 27.522 |
| Current Assets | - | - | - | - | - | - | 20 | 88 | 7.656 | 6.456 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 2.117 | 3.394 |
| Receivables | - | - | - | - | - | - | 20 | 0 | 355 | 842 |
| Cash | - | - | - | - | - | - | 0 | 88 | 5.184 | 2.220 |
| Shareholders Funds | - | - | - | - | - | - | 20 | 23 | 14.782 | 20.900 |
| Social Capital | - | - | - | - | - | - | 0 | 20 | 20 | 20 |
| Debts | - | - | - | - | - | - | 0 | 20.140 | 20.550 | 13.079 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5612 - 5612" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Dopamine Experiment S.r.l.